Christopher R. Fenimore Regeneron Pharmaceuticals, Inc. (REGN) insider trading activity

REGN Quotes by TradingView

Christopher R. Fenimore is SVP Finance & CFO of REGENERON PHARMACEUTICALS, INC.. Currently has a direct ownership of 14,372 shares of REGN, which is worth approximately $11.8 Million. The most recent transaction as insider was on Dec 11, 2021, when has been sold 270 shares (Common Stock) at a price of $664.34 per share, resulting in proceeds of $179,372. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.4K
0% 3M change
31.37% 12M change
Total Value Held $11.8 Million

Christopher R. Fenimore Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 11 2021
SELL
Payment of exercise price or tax liability
$179,372 $664.34 p/Share
270 Reduced 1.26%
21,122 Common Stock
Dec 08 2021
BUY
Grant, award, or other acquisition
-
1,859 Added 8.0%
21,392 Common Stock
Aug 23 2021
SELL
Open market or private sale
$3,160,624 $661.08 p/Share
4,781 Reduced 14.7%
27,739 Common Stock
Aug 20 2021
BUY
Exercise of conversion of derivative security
$2,418,255 $179.13 p/Share
13,500 Added 29.34%
32,520 Common Stock
Dec 09 2020
BUY
Grant, award, or other acquisition
-
2,719 Added 11.41%
21,102 Common Stock
CRF

Christopher R. Fenimore

SVP Finance & CFO
Tarrytown, NY

Track Institutional and Insider Activities on REGN

Follow REGENERON PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REGN shares.

Notify only if

Insider Trading

Get notified when an Regeneron Pharmaceuticals, Inc. insider buys or sells REGN shares.

Notify only if

News

Receive news related to REGENERON PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on REGN